Siemens Healthineers announced that it was selected by Quest Diagnostics to be its preferred supplier for immunoassay testing. When fully realized, this would be the largest deployment of the Atellica solution worldwide to date and strengthens the medical technology company’s position as the market leader in the United States.
As part of the multi-year agreement, which builds on an existing partnership, upon successful execution of sequenced phases, the partnership foresees Quest Diagnostics deploying up to 120 Atellica solution immunoassay analyzers across 19 esoteric and core laboratories throughout the U.S. Additionally, an automated Quest lab in Clifton, New Jersey, will feature Atellica solution immunoassay analyzers connected to an Inpeco FlexLab automation system for a high-throughput, multidisciplinary testing solution designed to substantially increase productivity, reduce turnaround time, decrease unwanted variations and lower operational costs. The new flagship lab is expected to be completed in 2021.
